The efficacy of serratus anterior plane block with different dose of dexmedetomidine

Phase 2

Conditions: pain in patients with tube thoracostomy.

Registration Number: IRCT20230213057405N1

Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 50

Inclusion Criteria

Patient consent to enter the study
physical condition class I-II according to the standards of the Association of Anesthesiologists
body mass index (BMI) less than 40 kg/m2
no pregnancy or breastfeeding
no history of coagulopathy or the use of anticoagulants
Ejection fraction higher than 30%, no history of conductive heart block (except for first degree heart block and controlled atrial fibrillation)
the patient's level of consciousness should be above 14
no acute or chronic hepatitis
no history of psychiatric disease
no need for complementary Renal treatment or history of kidney failure and no neuropathy
no history of drug or alcohol abuse

Exclusion Criteria

Allergy to the studied drugs
unwillingness of patients to cooperate

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Study groups, pain score, heart rate, systolic blood pressure, diastolic blood pressure, amount of narcotic drug use, oxygen saturation, duration of walking, duration of stay in ICU. Timepoint: nominal, distance, relative, ratio (in mm Hg), ratio (in mm Hg), ratio (in mg/k), ratio (in percentage), ratio (in minutes), ratio (in minutes). Method of measurement: According to the dose of dexmedetomidine, they are divided into two groups, 0.5 and 1. Based on the criteria, VNS describes the pain between numbers and 10, the number of heartbeats in one minute, systolic blood pressure measured by a sphygmomanometer, diastolic blood pressure measured by a sphygmomanometer, the amount of drug use. Narcotics to control the patient's pain, oxygen saturation percentage using pulse oximeter, time (using clock measurement), time (using clock measurement).

Secondary Outcome Measures